Evaluation of the AMPLICOR CMV test for direct detection of cytomegalovirus in plasma specimens.
about
Use of laboratory assays to predict cytomegalovirus disease in renal transplant recipients.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsComparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group.Comparison of PCR, antigenemia assay, and rapid blood culture for detection and prevention of cytomegalovirus disease after lung transplantationComparative quantitation of cytomegalovirus (CMV) DNA in solid organ transplant recipients with CMV infection by using two high-throughput automated systems.Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant.Prevention of cytomegalovirus disease in recipients of allogeneic stem cell transplantsFalse-positive results of plasma PCR for cytomegalovirus DNA due to delayed sample preparation.Quantitative analysis of cytomegalovirus (CMV) viremia using the pp65 antigenemia assay and the COBAS AMPLICOR CMV MONITOR PCR test after blood and marrow allogeneic transplantation.Qualitative plasma PCR assay (AMPLICOR CMV test) versus pp65 antigenemia assay for monitoring cytomegalovirus viremia and guiding preemptive ganciclovir therapy in allogeneic stem cell transplantation.Quantitation of cytomegalovirus: methodologic aspects and clinical applications.Evaluation of a new automated, standardized generic nucleic acid extraction method (total nucleic acid isolation kit) used in combination with cytomegalovirus DNA quantification by COBAS AMPLICOR CMV MONITOR.Detection of cytomegalovirus in plasma and cerebrospinal fluid specimens from human immunodeficiency virus-infected patients by the AMPLICOR CMV test.Evaluation of the AMPLICOR cytomegalovirus test with specimens from human immunodeficiency virus-infected subjects.Evaluation of the murex hybrid capture cytomegalovirus DNA assay versus plasma PCR and shell vial assay for diagnosis of human cytomegalovirus viremia in immunocompromised patientsMonitoring of viral load by quantitative plasma PCR during active cytomegalovirus infection of individual liver transplant patients.
P2860
Q33683157-24EE177A-D260-485B-8C6D-64A53BA77362Q33812425-7DABD36F-4AD3-42BD-ACA7-3D80D38B92D1Q33960205-CD55CC2C-3231-4B7C-AA0A-36398092D3BEQ33965505-4CA3FEFD-A5E3-48F0-86E2-CBA0A9B149C6Q33974336-8C009C71-1C62-4184-8BC6-7A5DA327E0A7Q34102747-53AFD408-001E-4932-A530-820066E8B8B0Q35558815-EEAE10BD-4FCA-46C9-9D52-20D37DED8F95Q39461150-153AF7D2-B4A8-4384-8B55-B64256C8CBB8Q39462398-4A7D6F9A-A8B5-4AC5-98E0-76E2294F39A8Q39466867-1C5949E0-E855-4378-8750-4D3BAD5C0441Q39468915-889F6D36-7E0E-4CBE-BB07-5FEA1C29B11EQ39488252-2DE29951-7B4F-4759-A4F5-12ED5E988C23Q39555322-C3307288-4E29-45E7-8C29-D538B7FFBAC2Q39555384-8B367B4B-6722-499E-A4E0-2DD2CB6C0B43Q39555420-06EB72AF-E47D-45A1-A9E5-CB59F716B6E6Q39628374-C0A0451A-2CED-4F61-8EE9-7418DC73612C
P2860
Evaluation of the AMPLICOR CMV test for direct detection of cytomegalovirus in plasma specimens.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@ast
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@en
type
label
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@ast
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@en
prefLabel
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@ast
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@en
P2093
P2860
P1476
Evaluation of the AMPLICOR CMV ...... galovirus in plasma specimens.
@en
P2093
Higashihata M
Shimaoka M
P2860
P304
P407
P577
1997-10-01T00:00:00Z